FDA Issues Guidance for Sponsors of Bispecific Antibody Therapies

Drug Industry Daily
A A
The FDA has drawn up draft guidance on developing bispecific antibodies to target multiple disease-modifying molecules with a single drug.

To View This Article:

Login

Subscribe To Drug Industry Daily